DR. HARLAN CLAYTON BIELEY, MD
Dermatology at Us Highway 1, West Palm Beach, FL
License number
Florida ME66700
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
649 Us Highway 1 SUITE 1, West Palm Beach, FL 33408
Phone
(561) 842-7422
(561) 385-2282
(561) 385-2282
Personal information
See more information about HARLAN CLAYTON BIELEY at radaris.comName
Address
Phone
616 Clearwater Park Rd APT 8, West Palm Beach, FL 33401
5640 Collins Ave, Miami Beach, FL 33140
9404 SW 77Th Ave, Miami, FL 33156
9352 SW 77Th Ave, Miami, FL 33156
616 Clearwater Park Rd #803, West Palm Beach, FL 33401
Professional information
See more information about HARLAN CLAYTON BIELEY at trustoria.com
Dr. Harlan C Bieley, North Palm Beach FL - MD (Doctor of Medicine)
Dr. Harlan C Bieley, North Palm Beach FL - MD (Doctor of Medicine)
Specialties:
Preventive Medicine, Dermatology
Address:
Healthy Living and Longevity Medical Center
649 Us Highway 1 SUITE 1, North Palm Beach 33408
(561) 842-7422 (Phone), (561) 842-0848 (Fax)
649 Us Highway 1 SUITE 1, North Palm Beach 33408
(561) 842-7422 (Phone), (561) 842-0848 (Fax)
Procedures:
Botox, captique, collagen, hylaform & restylane injections, Botox® injections, Juvederm, Restylane injections
Conditions:
Adrenal disorders, Food, Nutrition and Metabolism - Weight Loss and Dieting, Genetic Testing, Hormone Imbalances, HORMONE PROBLEMS, Hypothyroidism, Lead poisoning, Low Testosterone, Mercury Poisoning, Mold Allergies, PMS, Sexual Problems, Toxic Exposures, Women's Health - Menopause
Languages:
English
Philosophy:
I am passionate about my work personalized, customized Anti-Aging and Functional Medicine. This work is focused on improving your overall functioning so that you lead a better life. We do more than just treat symptoms, we look for underlying causes of illness and address those issues.
Education:
Medical School
Univ Of Miami Sch Of Med
Graduated: 1992
Central Texas Med Foundn
Graduated: 1993
Austin Med Educ Program Seton Hlt
Jfk Med Center
Med College Of Ga Hospital and Cli
The Med Center Inc
University of Miami
Graduated: 1996
Univ Of Miami Sch Of Med
Graduated: 1992
Central Texas Med Foundn
Graduated: 1993
Austin Med Educ Program Seton Hlt
Jfk Med Center
Med College Of Ga Hospital and Cli
The Med Center Inc
University of Miami
Graduated: 1996
Smoking Cessation Treatment With Appetite Suppression
Smoking Cessation Treatment With Appetite Suppression
US Patent:
2008010, May 1, 2008
Filed:
Oct 30, 2006
Appl. No.:
11/554364
Inventors:
Harlan Clayton Bieley - West Palm Beach FL, US
International Classification:
A61K 31/714, A61K 31/525, A61K 31/51, A61K 31/385, A61K 31/375, A61K 31/198, A61K 31/405
US Classification:
514 52, 514350, 514342, 514440, 514276, 514567, 514554, 514419, 514562, 514561, 514474, 514251, 514250
Abstract:
A multi-component compound for the simultaneous treatment of nicotine addiction and the side effects of nicotine withdrawal, such as excessive appetite. The first component is a bivalent negative sulfur compound in an amount effective to control nicotine craving or the withdrawal symptoms resulting from nicotine withdrawal. The bivalent negative sulfur is selected from a group that includes, but is not limited to, alkyl sulfides, colloidal sulfur, hydropersulfides, organic thio compounds or their salts. The second component is a serotonin precursor, such as tryptophan or its derivative 5-HTP, which is used to assist the body in producing more serotonin which in turn suppresses appetite. The appetite suppressant(s) are combined with the bivalent negative sulfur compound(s) to provide a single compound that reduces nicotine craving and simultaneously suppresses increased appetite resulting from nicotine withdrawal.
Smoking Cessation With Body Weight Maintenance And Nutritional Supplement
Smoking Cessation With Body Weight Maintenance And Nutritional Supplement
US Patent:
2011001, Jan 20, 2011
Filed:
Sep 29, 2010
Appl. No.:
12/893910
Inventors:
Harlan Clayton Bieley - West Palm Beach FL, US
International Classification:
A61K 9/127, A61K 38/43, A24F 47/00, A61K 31/675, A61K 31/4188, A61K 31/714, A61K 31/4045, A61K 31/137, A61K 31/14, A61K 33/06, A61K 31/355, A61K 31/519, A61K 33/32, A61K 31/525, A61K 31/07, A61K 31/375, A61K 33/04, A61K 33/30, A61K 31/59, A61K 38/06, A61K 31/7076, A61K 36/68, A61K 31/198, A61K 38/44, A61K 31/22, A61P 43/00
US Classification:
424450, 424 941, 131270, 514 89, 514387, 514 52, 514419, 514654, 514415, 514642, 424722, 514458, 514249, 424639, 514251, 514725, 514474, 424702, 424641, 514167, 514 219, 514 46, 424725, 514562, 424 944, 514546
Abstract:
Disclosed is a compound and methods for use by an individual attempting to reduce or cease tobacco smoking or one exposed to environmental tobacco smoke. The compound includes a first component blocking nicotine receptor sites to reduce nicotine cravings or withdrawal symptoms, a second component increasing serotonin levels and acting synergistically with the first component to reduce nicotine cravings or withdrawal symptoms, assisting in maintaining body weight and reducing increased stress and anxiety, and a third component acting synergistically with the first and/or second component to reduce nicotine cravings or withdrawal symptoms, maintain body weight, and/or reduce increased stress and anxiety. The third component comprises a supplement that replenishes depleted body substance(s), repairs damaged body substance(s), and/or ameliorates the impaired function of body substance(s). Some combination of the first, second, and third component alters the perceived taste of tobacco smoke.
Smoking Cessation Treatment By Reducing Nicotine Cravings, Apetite Suppression, And Altering The Perceived Taste Of Tobacco Smoke
Smoking Cessation Treatment By Reducing Nicotine Cravings, Apetite Suppression, And Altering The Perceived Taste Of Tobacco Smoke
US Patent:
2010002, Jan 28, 2010
Filed:
Sep 30, 2009
Appl. No.:
12/571391
Inventors:
Harlan Clayton Bieley - West Palm Beach FL, US
International Classification:
A61K 31/714, A61P 25/34, A61K 36/84, A61K 36/67, A61K 36/82
US Classification:
424729, 514 52, 424725
Abstract:
A multi-component compound for the simultaneous treatment of nicotine addiction and the side effects of nicotine withdrawal, such as excessive appetite. The first component is a bivalent negative sulfur compound in an amount effective to control nicotine craving or the withdrawal symptoms resulting from nicotine withdrawal. The bivalent negative sulfur is selected from a group that includes, but is not limited to, alkyl sulfides, colloidal sulfur, hydropersulfides, organic thio compounds or their salts. The second component is a serotonin precursor, such as tryptophan or its derivative 5-HTP, which is used to assist the body in producing more serotonin which in turn suppresses appetite. The appetite suppressant(s) are combined with the bivalent negative sulfur compound(s) to provide a single compound that reduces nicotine craving and simultaneously suppresses increased appetite resulting from nicotine withdrawal. The compound alters the perceived taste of tobacco smoke such that it is no longer enjoyable.
Replacement Of Vitamins, Minerals And Neurotransmitter Losses From Tobacco Smoking
Replacement Of Vitamins, Minerals And Neurotransmitter Losses From Tobacco Smoking
US Patent:
2008010, May 1, 2008
Filed:
Jan 3, 2008
Appl. No.:
11/969199
Inventors:
Harlan Bieley - West Palm Beach FL, US
International Classification:
A61K 33/30, A61P 43/00
US Classification:
424641000
Abstract:
A compound for the simultaneous treatment of nicotine addiction, the side effects of nicotine withdrawal, such as excessive appetite, and detrimental health effects caused by loss of vital body substances such as vitamins, minerals, amino acids, co-factors and neurotransmitters which result from tobacco smoking. The first component is a bivalent negative sulfur compound from a group that includes, but is not limited to, alkyl sulfides, colloidal sulfur, hydropersulfides, organic thio compounds or their salts. The second component is a replenishment formula which is used to correct losses of those substances caused by tobacco smoke. The first and second components can be used alone, or in combination.